AR017664A1 - Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento - Google Patents

Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento

Info

Publication number: AR017664A1
Authority: AR; Argentina
Prior art keywords: manufacture; pharmaceutical formulations; glucosidase inhibitors; medicinal product; alfa
Prior art date: 1997-11-25

Application number

ARP980105946A

Other languages

English (en)

Spanish (es)

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-25

Filing date

1998-11-24

Publication date

2001-09-12

1998-11-24 Application filed by Bayer Ag filed Critical Bayer Ag

2001-09-12 Publication of AR017664A1 publication Critical patent/AR017664A1/es

Links

238000004519 manufacturing process Methods 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
230000002459 sustained effect Effects 0.000 title 1
XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 abstract 1
229940077274 Alpha glucosidase inhibitor Drugs 0.000 abstract 1
IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 abstract 1
FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 abstract 1
229960002632 acarbose Drugs 0.000 abstract 1
XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 abstract 1
239000003888 alpha glucosidase inhibitor Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229960001110 miglitol Drugs 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1
229960001729 voglibose Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ARP980105946A 1997-11-25 1998-11-24 Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento AR017664A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6669897P	1997-11-25	1997-11-25

Publications (1)

Publication Number	Publication Date
AR017664A1 true AR017664A1 (es)	2001-09-12

Family

ID=22071124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP980105946A AR017664A1 (es)	1997-11-25	1998-11-24	Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento

Country Status (5)

Country	Link
JP (1)	JP2001523704A (fr)
AR (1)	AR017664A1 (fr)
AU (1)	AU1234399A (fr)
WO (1)	WO1999026606A2 (fr)
ZA (1)	ZA9810710B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1157696B1 (fr) *	2000-05-24	2006-10-25	Pfizer Limited	Traitement de l'acidité du rumen avec amylase inhibiteurs
GB0203296D0 (en)	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
RU2356906C2 (ru)	2002-08-08	2009-05-27	Киссеи Фармасьютикал Ко., Лтд.	Производные пиразола, лекарственные композиции, содержащие эти производные, их применение в медицине и промежуточные соединения для их получения
CN1950389B (zh)	2004-03-04	2011-01-19	橘生药品工业株式会社	含氮稠环衍生物，含该衍生物的药物组合物，和其作为药物的用途
CN102631332A (zh) *	2012-04-28	2012-08-15	邹立兴	一种伏格列波糖片剂及其制备方法
CN104013590A (zh) *	2014-05-09	2014-09-03	万特制药(海南)有限公司	一种含阿卡波糖的药物组合物及其制备方法
WO2016001843A1 (fr) *	2014-06-30	2016-01-07	Sun Pharmaceutical Industries Limited	Comprimés de voglibose à rétention gastrique et à libération prolongée
KR101937069B1 (ko) *	2014-12-17	2019-04-03	엠프로스 파마 악티에볼라그	비만 및 관련 대사 장애의 치료를 위한 오를리스타트 및 아카르보스의 변형 방출형 조성물
CN110898025A (zh) *	2019-12-12	2020-03-24	湖北欣泽霏药业有限公司	阿卡波糖缓释制剂及其制备方法
CN111265489A (zh) *	2020-03-10	2020-06-12	乐普制药科技有限公司	一种可分割型阿卡波糖微丸缓释片剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3134591A1 (de) *	1981-09-01	1983-03-10	Bayer Ag, 5090 Leverkusen	Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
AU596961B2 (en) *	1985-03-08	1990-05-24	Takeda Chemical Industries Ltd.	Saccharide digestion inhibiting composition
EP0364696B1 (fr) *	1988-08-22	1993-03-17	Takeda Chemical Industries, Ltd.	Inhibiteur de l'alpha-glucosidase pour la promotion de l'absorption de calcium
TW272942B (fr) *	1993-02-10	1996-03-21	Takeda Pharm Industry Co Ltd

1998
- 1998-11-11 JP JP2000521808A patent/JP2001523704A/ja active Pending
- 1998-11-11 WO PCT/EP1998/007198 patent/WO1999026606A2/fr not_active Ceased
- 1998-11-11 AU AU12343/99A patent/AU1234399A/en not_active Abandoned
- 1998-11-24 AR ARP980105946A patent/AR017664A1/es unknown
- 1998-11-24 ZA ZA9810710A patent/ZA9810710B/xx unknown

Also Published As

Publication number	Publication date
ZA9810710B (en)	1999-06-14
WO1999026606A3 (fr)	1999-08-12
AU1234399A (en)	1999-06-15
WO1999026606A2 (fr)	1999-06-03
JP2001523704A (ja)	2001-11-27

Similar Documents

Publication	Publication Date	Title
AR011069A1 (es)	2000-08-02	Compuestos amidino, proceso para su preparacion, compuestos intermediarios, formulaciones farmaceuticas que los comprenden, y su uso en la fabricacion de un medicamento como inhibidor de la oxido nitrico sintasa inducible.
AR012671A1 (es)	2000-11-08	Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
UY26372A1 (es)	2000-12-29	"imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ES2113444T3 (es)	1998-05-01	Medicamentos.
ES2196377T3 (es)	2003-12-16	Derivados de naftiridina.
ES2114588T3 (es)	1998-06-01	Forma farmaceutica de un gel acuoso que contiene un retinoide.
ES2178430T3 (es)	2002-12-16	Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ES2054860T5 (es)	2003-11-01	Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ECSP941104A (es)	1994-12-15	Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
UY26258A1 (es)	2000-12-29	Derivados de 8-fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-ona.
ES2161085T3 (es)	2001-11-16	Formulaciones que contienen oxaliplatino.
AR004700A1 (es)	1999-03-10	1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
AR032293A1 (es)	2003-11-05	Estuche farmaceutico
AR012125A1 (es)	2000-09-27	UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE
UY24986A1 (es)	2001-08-27	Compuestos
AR017664A1 (es)	2001-09-12	Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento
ES2171691T3 (es)	2002-09-16	Derivados de la colchicina, uso de los mismos y formulaciones que los contienen.
ES2160680T3 (es)	2001-11-16	Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
AR021843A1 (es)	2002-08-07	Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
UY25192A1 (es)	2001-08-27	Formulación medicamentosa con liberación controlada de sustancia activa
UY26371A1 (es)	2000-10-31	Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
AR028448A1 (es)	2003-05-07	Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
PY0117547A (es)	2003-11-03	Composicion de eletriptan en forma de particulas.
AR021086A1 (es)	2002-06-12	Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.
ES2156215T3 (es)	2001-06-16	Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.